drugset / Trial / NCT07516717

Intrathecal Morphine 75 mcg Versus 100 mcg for Post-Cesarean Analgesia: A Randomized Double-blind Trial

NCT07516717

Phase 4 Completed 240 enrolled Hospital Universitario de Caracas
RandomizedParallel-groupDouble-blindTreatment

Summary

This study evaluates the efficacy and safety of two different doses of intrathecal morphine (75 mcg versus 100 mcg) for postoperative analgesia in patients undergoing elective cesarean delivery under spinal anesthesia. Effective postoperative pain control is essential to improve maternal recovery, facilitate early mobilization, and enhance neonatal care. Participants were randomly of assigned to receive either 75 mcg or 100 mcg of intrathecal morphine dose that provides effective analgesia while minimizing adverse effects in the obstetric population.

Timeline

Start
2023-01-07
Primary completion
2024-06-15
Completion
2024-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 75 ug Other
Subject Morphine Other / unclassified 100 ug Other

Indications

No indication recorded.